3/A

PRIMARY DOCUMENT

Company: BIOCRYST PHARMACEUTICALS INC
Filed: May 18, 2004
Period of Report: May 17, 2004
Accession Number: 0001282930-04-000028

View Document ↗ View on SEC.gov ↗